Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 65551-65600 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06189092
Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study
N/ARecruiting
65 participants
Started: Oct 28, 2023 · Completed: Nov 28, 2027
1 condition1 sponsor1 location
NCT05977894
Floatation Experience in Nurses and Physicians
N/AEnrolling by invitation
50 participants
Started: Oct 28, 2023 · Completed: May 5, 2026
6 conditions1 sponsor1 location
NCT05794542
Cue X as a Treatment for People With Parkinson's Disease
NARecruiting
30 participants
Started: Oct 28, 2023 · Completed: May 1, 2024
1 condition1 sponsor1 location
NCT06103149
The Role of Cognitive Flexibility in Mindfulness Intervention: a Functional Near-infrared Spectroscopy Study
NANot yet recruiting
200 participants
Started: Oct 28, 2023 · Completed: Dec 24, 2024
1 condition1 sponsor1 location
NCT06113653
Outcomes and Predictors of Mortality Among Preterm Infants With Neonatal Sepsis
N/ANot yet recruiting
50 participants
Started: Oct 28, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor0 locations
NCT06035549
Resilience in East Asian Immigrants for Advance Care Planning Discussions
NARecruiting
54 participants
Started: Oct 27, 2023 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT06787326
Effect of the BioFire FilmArray (BCID2) for the Rapid Detection of Bloodstream Infection in Haematologic Patients With Febrile Neutropenia
N/AActive, not recruiting
228 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06105151
Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers
PHASE1Recruiting
82 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06171217
Realizing Effectiveness Across Continents With Hydroxyurea
PHASE2Active, not recruiting
810 participants
Started: Oct 27, 2023 · Completed: Oct 4, 2033
2 conditions2 sponsors4 locations
NCT05978284
Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
PHASE1/PHASE2Recruiting
54 participants
Started: Oct 27, 2023 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT05980000
Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma
PHASE2Recruiting
72 participants
Started: Oct 27, 2023 · Completed: Apr 30, 2031
6 conditions2 sponsors1 location
NCT06083012
Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation
N/ARecruiting
150 participants
Started: Oct 27, 2023 · Completed: Apr 27, 2027
3 conditions2 sponsors7 locations
NCT06039176
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
N/ARecruiting
150 participants
Started: Oct 27, 2023 · Completed: Dec 25, 2026
8 conditions11 sponsors8 locations
NCT06108323
Immediate Effects of Mental Practice and Therapeutic Exercise in Mild Smokers
NAActive, not recruiting
34 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05743595
Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
PHASE1Recruiting
12 participants
Started: Oct 27, 2023 · Completed: Jan 31, 2030
1 condition4 sponsors1 location
NCT04276116
"Effectiveness of the Evaluation and Communication of Pulmonary Age as Help for Smoking Cessation"
NARecruiting
800 participants
Started: Oct 27, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06123104
Assessment of Automatic Tourniquets for Soldiers During Wartime
NARecruiting
10 participants
Started: Oct 27, 2023 · Completed: Dec 30, 2024
2 conditions1 sponsor1 location
NCT06304753
ContriBution of Digital RemOte MoniToring to IMPROVing The Effectiveness of Treatment in Patients With Chronic Heart Failure With Low Ejection Fraction
NARecruiting
60 participants
Started: Oct 27, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor2 locations
NCT06032104
Feasibility and Colorectal Benefits of Pulses Supplementation
NARecruiting
25 participants
Started: Oct 27, 2023 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT06099457
SIBTime Phase II: Web Application for Typically Developing Siblings
NARecruiting
160 participants
Started: Oct 27, 2023 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT06122558
Efficacy of Probiotic Against Functional Constipation
PHASE2Recruiting
104 participants
Started: Oct 27, 2023 · Completed: Oct 26, 2025
1 condition2 sponsors2 locations
NCT05933083
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
NARecruiting
516 participants
Started: Oct 27, 2023 · Completed: Oct 15, 2027
6 conditions6 sponsors5 locations
NCT05786131
Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI
NARecruiting
3,390 participants
Started: Oct 27, 2023 · Completed: Jul 31, 2027
2 conditions5 sponsors58 locations
NCT05650736
Janus Kinase Inhibition in Granuloma Annulare
PHASE2Active, not recruiting
10 participants
Started: Oct 27, 2023 · Completed: Jul 1, 2025
1 condition3 sponsors1 location
NCT06078540
A Mobile Health (mHealth) Strategy for Improving Blood Pressure Control Among Adult Hypertensive African Americans
NARecruiting
30 participants
Started: Oct 27, 2023 · Completed: Oct 31, 2026
2 conditions1 sponsor1 location
NCT05985915
A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.
PHASE3Active, not recruiting
613 participants
Started: Oct 27, 2023 · Completed: Jul 18, 2030
1 condition1 sponsor196 locations
NCT05658497
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
N/ARecruiting
908 participants
Started: Oct 27, 2023 · Completed: Jul 6, 2032
1 condition1 sponsor7 locations
NCT06014099
Research on the Application of Blood Collection Through Midline Catheters of Different Lengths
NANot yet recruiting
162 participants
Started: Oct 27, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06109064
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS
PHASE2Recruiting
14 participants
Started: Oct 27, 2023 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT06170411
Post-marketing Clinical Trial of Elexir(Trigeminal Nerve Electrical Stimulator) for the Acute Treatment of Migraine
NARecruiting
100 participants
Started: Oct 27, 2023 · Completed: Aug 1, 2024
1 condition1 sponsor2 locations
NCT06938464
Preventive Effect of Probiotics in GDM
NARecruiting
334 participants
Started: Oct 27, 2023 · Completed: Nov 1, 2026
1 condition2 sponsors1 location
NCT06008288
A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.
PHASE2Recruiting
88 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2027
3 conditions1 sponsor31 locations
NCT06119958
Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects
PHASE1Recruiting
32 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT06113315
A Study of Immunotherapy Treatment in People With Sarcoma
N/AEnrolling by invitation
250 participants
Started: Oct 27, 2023 · Completed: Oct 31, 2028
1 condition1 sponsor7 locations
NCT06057350
Surgery Versus Endoscopic Resection for Incompletely Removed Early Colon CAnceR
NARecruiting
304 participants
Started: Oct 27, 2023 · Completed: Sep 30, 2033
2 conditions13 sponsors3 locations
NCT05914064
Gravitas Feeding Tube System Placement Validation in Neonates
NARecruiting
110 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor3 locations
NCT06492980
A Triple-branched Stent Graft for Aute Debakey Type I Dissection Surgery
NARecruiting
150 participants
Started: Oct 27, 2023 · Completed: Oct 10, 2025
1 condition1 sponsor1 location
NCT05918302
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
PHASE3Recruiting
120 participants
Started: Oct 27, 2023 · Completed: Jul 31, 2028
3 conditions3 sponsors23 locations
NCT06319235
Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®
PHASE1/PHASE2Recruiting
52 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2025
5 conditions1 sponsor1 location
NCT06267131
Transcutaneous Pulse Oximetry Brain Monitoring Study (US)
NARecruiting
15 participants
Started: Oct 27, 2023 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT06254911
Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
PHASE2Recruiting
20 participants
Started: Oct 27, 2023 · Completed: Dec 16, 2026
1 condition3 sponsors1 location
NCT07122479
Prevention of Hospital Acquired Deconditioning in Hospitalized Acute Leukemia Patients
NAActive, not recruiting
50 participants
Started: Oct 27, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor2 locations
NCT06044662
Prognostic Value of Biomarkers in Polyneuropathy.
N/ARecruiting
200 participants
Started: Oct 27, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06156956
Fecal Microbiota Transplantation (FMT) to Decolonize Antibiotic - Resistant Bacteria (ARB) - New Protocol
NARecruiting
200 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor5 locations
NCT05900206
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
PHASE2Recruiting
370 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2032
1 condition1 sponsor7 locations
NCT06155643
EKO SENSORA: Detecting Clinically Significant Murmurs
EARLY_PHASE1Recruiting
300 participants
Started: Oct 26, 2023 · Completed: Jul 26, 2025
1 condition1 sponsor1 location
NCT05892614
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
PHASE2Recruiting
25 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor15 locations
NCT06161922
Real World Patient-Reported Outcomes in Chinese Her2+ EBC Patients Receiving (Neo) Adjuvant Anti-Her2 Based Therapy
N/ARecruiting
600 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05962450
Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy
PHASE2Recruiting
84 participants
Started: Oct 26, 2023 · Completed: Aug 1, 2025
1 condition2 sponsors1 location
NCT05774652
LiPO Teen (the Lifestyle in Pregnancy and Offspring Teenagers
NARecruiting
301 participants
Started: Oct 26, 2023 · Completed: Apr 1, 2026
5 conditions6 sponsors1 location